<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Banfi C</submitter><funding>Ministero della Salute</funding><funding>Italian Ministry of Health, Italy, Ricerca Corrente 2021, Centro Cardiologico Monzino IRCCS</funding><pagination>542</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10045348</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(3)</volume><pubmed_abstract>The process of adipogenesis involves the differentiation of preadipocytes into mature adipocytes. Excessive adipogenesis promotes obesity, a condition that increasingly threatens global health and contributes to the rapid rise of obesity-related diseases. We have recently shown that prenylcysteine oxidase 1 (PCYOX1) is a regulator of atherosclerosis-disease mechanisms, which acts through mechanisms not exclusively related to its pro-oxidant activity. To address the role of PCYOX1 in the adipogenic process, we extended our previous observations confirming that Pcyox1&lt;sup>-/-&lt;/sup>/Apoe&lt;sup>-/-&lt;/sup> mice fed a high-fat diet for 8 or 12 weeks showed significantly lower body weight, when compared to Pcyox1&lt;sup>+/+&lt;/sup>/Apoe&lt;sup>-/-&lt;/sup> mice, due to an evident reduction in visceral adipose </pubmed_abstract><journal>Antioxidants (Basel, Switzerland)</journal><pubmed_title>Prenylcysteine Oxidase 1 Is a Key Regulator of Adipogenesis.</pubmed_title><pmcid>PMC10045348</pmcid><funding_grant_id>RF 2013-02355543</funding_grant_id><pubmed_authors>Gianazza E</pubmed_authors><pubmed_authors>Baetta R</pubmed_authors><pubmed_authors>Mallia A</pubmed_authors><pubmed_authors>Banfi C</pubmed_authors><pubmed_authors>Brioschi M</pubmed_authors><pubmed_authors>Sahlen P</pubmed_authors><pubmed_authors>Ghilardi S</pubmed_authors><pubmed_authors>Eligini S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prenylcysteine Oxidase 1 Is a Key Regulator of Adipogenesis.</name><description>The process of adipogenesis involves the differentiation of preadipocytes into mature adipocytes. Excessive adipogenesis promotes obesity, a condition that increasingly threatens global health and contributes to the rapid rise of obesity-related diseases. We have recently shown that prenylcysteine oxidase 1 (PCYOX1) is a regulator of atherosclerosis-disease mechanisms, which acts through mechanisms not exclusively related to its pro-oxidant activity. To address the role of PCYOX1 in the adipogenic process, we extended our previous observations confirming that Pcyox1&lt;sup>-/-&lt;/sup>/Apoe&lt;sup>-/-&lt;/sup> mice fed a high-fat diet for 8 or 12 weeks showed significantly lower body weight, when compared to Pcyox1&lt;sup>+/+&lt;/sup>/Apoe&lt;sup>-/-&lt;/sup> mice, due to an evident reduction in visceral adipose </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-04-08T14:13:01.632Z</modification><creation>2025-02-19T02:38:37.48Z</creation></dates><accession>S-EPMC10045348</accession><cross_references><pubmed>36978789</pubmed><doi>10.3390/antiox12030542</doi></cross_references></HashMap>